The Board of Directors of Brighter calls an Extraordinary General Meeting and proposes that the Meeting decides on a directed new issue.

The Board of Directors of Brighter AB (publ) ("Brighter" or "the Company") has today decided to call an Extraordinary General Meeting of the Company on November 11, 2019, and proposes that the Meeting decides on a directed new share issue as compensation for warrants not registered with the Swedish Companies Registration Office. Notice of the Annual General Meeting is published through a special press release.

The main content of the proposal for the private placement is set out below. For more detailed information on the proposal, please refer to the notice of the meeting and the complete proposal. The complete proposal will be available on the Company's website, www.brighter.se, by October 28, 2019.

The Board's proposal for a directed share issue

Summary

The Board of Directors proposes that the Meeting decides on a new share issue to those who would have been the holder of warrants in Program 2016/19 Series I (then Board members) and Program 2016/19 Series II (then Staff and Key Persons), resolved by the Annual General Meeting on May 17, 2016. The resolved warrants in Program 2016/19 Series I and Program 2016/19 Series II were inadvertently never registered with the Swedish Companies Registration Office. In order to compensate those who would have held the warrants for their absent opportunity to subscribe for shares in the Company, these persons are given the right to subscribe for shares within the framework of the new share issue.

The new share issue comprises a maximum of 2,629,430 shares at a subscription price of SEK 7.30 per share, which at full subscription corresponds to approximately SEK 19.2 million in issue proceeds before issue costs. The subscription price corresponds to the recalculated strike price (strike price) according to the terms of the warrants in Program 2016/19 Series I and Program 2016/19 Series II. The subscription price is based on the new issue being compensation for the subscribers not receiving the warrants they had been granted and had paid for in the said program, and that the subscribers have paid the market value for the relevant warrants.

Upon full subscription, the total number of shares in the Company will increase by 2,629,430 from 93,397,483 to 96,026,913 and the share capital will increase by SEK 131,471.50 from SEK 4,669,874.15 to SEK 4,801,345.65, corresponding to a dilution of votes and capital of approximately 2.7 percent.

Main issue conditions

1. The company's share capital shall be increased by a maximum of SEK 131,471.50 through a new share issue of a maximum of 2,629,430 shares.
2. The subscription of shares shall take place from 11 November 2019 to 18 November 2019.
3. The subscription price shall be SEK 7.30 per share.
4. Payment for subscribed shares shall be paid in cash by November 25, 2019.
5. The allocation of shares shall be made to the subscribers pro rata in relation to the number of warrants they would have held in program 2016/19 series I and program 2016/19 series II, if the warrants had been registered with the Swedish Companies Registration Office.
6. The new shares shall entail the right to a dividend for the first time on the record date for a dividend that falls closest to the date after the shares have been included in the share register kept by Euroclear Sweden AB.
7. For the Meeting's decision to be valid, the support of shareholders representing at least nine tenths of both the votes cast and the shares represented at the Meeting is required.

For further information, please contact:

Henrik Norström, CEO   
Phone: +46 733 40 30 45      
Email: henrik.norstrom@brighter.se

Ann Zetterberg, CFO
Phone: +46 708 37 21 23
E-mail: ann.zetterberg@brighter.se

About Brighter AB (publ).
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/

The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, info@eminova.se, www.eminova.se.

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 15:45 CET on October 23, 2019.